Source: Annual Congress 2004 - Lung fibrosis sarcoidosis alveolar microlithiasis and proteinosis



Rating:

Share or cite this content

Citations should be made in the following way:
M. Demedts, J. Behr, R. Buhl, U. Costabel, H. M. Jansen, M. Thomeer, B. Wallaert, I. Lankhorst, M. Sardina, G. Corvasce, M. Montanari, F. Laurent, J. Verschakelen, C. D. R. Flower (Leuven, Belgium). IFIGENIA-study in IPF: effects of N-acetylcysteine (NAC) on CRP, dyspnea, exercise test and HRCT. Eur Respir J 2004; 24: Suppl. 48, 4077

Member's Comments

No comment yet.

Related content which might interest you: CT scan derived emphysema scores correlate with spirometry and gas exchange but not acute exacerbation rates (AER) or COPD assessment test (CAT) in COPD subjects with and without alpha-1-antitrypsin (AAT) deficiency Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Combination of six-minute walk test (6MWT) and exhaled carbon monoxide (eCO) measurement in patients with exogenous allergic alveolitis (EAE) and idiopathic pulmonary fibrosis (IPF) – test of a new approach Source: Eur Respir J 2007; 30: Suppl. 51, 580s Year: 2007 The relationship between the lung function and dyspnea, cough, and exercise capacity in the not-treated COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 511s Year: 2005 The role of cardio pulmonary exercise testing (CPET) in patients with cystic fibrosis (CF) Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 The effects of adding formoterol (F) and tiotropium (T) on exercise performance and breathlessness in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 577s Year: 2005 Correlation of dyspnea scores with pulmonary function, high-resolution computed tomography (HRCT) and exercise capacity in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 305s Year: 2006 The performance of COPD assessment test (CAT) in mustard lung patients Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012 The EDD (exercise, DLco, dyspnea) index in diffuse systemic sclerosis with pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Cardiopulmonary exercise test (CPET) may show initial left cardiac dysfunction in patients with moderate-severe chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 A six minute walking test (6MWT) derived index (O2-GAP) predicts mortality in IPF Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Comparative evaluation on the synergism of roflumilast (RFL) and glycopyrronium (Gly) vs ciclesonide (CLS) and Gly on lung volumes and exercise tolerance in severe COPD Source: International Congress 2015 – Clinical exercise physiology in health and disease Year: 2015 IFIGENIA (idiopathic pulmonary fibrosis international group exploring NAC I annual): effects of N-acetylcysteine (NAC) on lung function and gas exchange in IPF pati Source: Eur Respir J 2004; 24: Suppl. 48, 668s Year: 2004 Salmeterol/fluticasone propionate (SFC) improves the inspiratory to total lung capacity ratio (IC/TLC) and exercise endurance time in patients with COPD Source: Annual Congress 2006 - COPD therapy Year: 2006 Effects of oxygen inhalation during exercise in patients with combined pulmonary fibrosis and emphysema (CPFE) Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010 Subjective (CAT, MMRC) versus objective (PFT, 6MWD, SPO2) assessment in stable COPD patients Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care Year: 2012 Correlation of induced sputum (IS) particles size distribution (PDS) and pulmonary function test (PFT) in asthmatics patients (A-pts) Source: Eur Respir J 2004; 24: Suppl. 48, 604s Year: 2004 Endurance shuttle walking test: responsiveness to salmeterol in COPD Source: Eur Respir J 2008; 31: 579-584 Year: 2008 COPD phenotypes by high resolution computed tomography (HRCT) and ventilatory response to exercise Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles Year: 2015 Four weeks of treatment with n-acetyl cysteine (NAC) (1200mg/day) reduces lung oxidative stress and improves lung function in moderate-to-severe COPD subjects Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Metronome-paced hyperventilation, CT measurements and exercise to investigate dynamic hyperinflation contrasting tiotropium versus indacaterol treatment in moderate COPD patients Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease Year: 2015